Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ondernemend Oranje Kapitaal (OOK) is a Dutch venture capital and private equity firm that specializes in investing in innovative small and medium-sized enterprises within the Netherlands. The firm maintains a strong focus on the life sciences and healthcare sectors, providing growth capital to companies developing advanced medical technologies and therapeutic solutions. OOK's portfolio includes notable clinical-stage biotechnology companies such as VarmX and Lava Therapeutics, as well as medical device firms like Xeltis and ONWARD Medical. Beyond financial investment, the firm offers strategic support and leverages its extensive network to help portfolio companies navigate the path to commercialization. OOK is recognized for its commitment to fostering Dutch entrepreneurship and supporting high-impact innovations that address significant medical challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ondernemend Oranje Kapitaal.